SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-17-009301
Filing Date
2017-02-14
Accepted
2017-02-14 16:37:38
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G a17-4357_2sc13g.htm SC 13G 69389
  Complete submission text file 0001104659-17-009301.txt   70668
Mailing Address 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152
Business Address 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152 248-980-6538
Gemphire Therapeutics Inc. (Subject) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89598 | Film No.: 17609620
SIC: 2834 Pharmaceutical Preparations

Mailing Address 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152
Business Address
Sooch Mina (Filed by) CIK: 0001674006 (see all company filings)

Type: SC 13G